NEPH (Nephros) FFO


NEPH Nephros Inc NEPH
63 GF Score
Price $3.44
GF Value $2.87
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Nephros FFO?

FFO (Funds from operations) only applies to REITs.

NEPH
63GF Score
Nephros Inc NEPH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nephros (NEPH) Overvalued in 2026?

Based on GuruFocus' analysis, Nephros stock appears to be overvalued. The current stock price of $3.44 is trading 19.9% above its estimated GF Value™ of $2.87. GuruFocus considers Nephros to be Modestly Overvalued.

Key valuation signals for NEPH:

  • FFO:
  • GF Value™: $2.87 vs. price of $3.44 (19.9% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NEPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nephros Business Description

Other Exchanges NPJP:Germany
Address 380 Lackawanna Place, South Orange, NJ, USA, 07079
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
63GF Score

Get the complete analysis for NEPH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.44
Price
$2.87
GF Value